Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

NCT01808534 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Due to Low Accrual

Conditions

Adult Central Nervous System Germ Cell Tumor
Adult Teratoma
Malignant Extragonadal Germ Cell Tumor
Malignant Extragonadal Non-Seminomatous Germ Cell Tumor
Extragonadal Seminoma
Recurrent Malignant Testicular Germ Cell Tumor
Recurrent Ovarian Germ Cell Tumor
Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor
Stage IV Extragonadal Seminoma
Stage IV Ovarian Germ Cell Tumor

Interventions

DRUG: palifosfamide

Sponsor

Indiana University

Collaborators

[object Object]